higher yield loss; and cost from relocating some product from the old production line to the new one in Q1/2018. Q3/2018 Gross Profit The Company and its subsidiaries recorded gross profit of Baht 249

net realizable value, the Company would have posted a net profit of 9.1mn. Losses per share in 1Q18 was THB 0.02. 1 Backlogs are counted only when sale and purchase agreement is signed Management

measurable advertising. This places the Company in a favourable position to offer optimal solutions to our customers as well as continuing to capture market share in the OOH and Online/Digital media. Our 9

launched the roasted seaweed categories and conducted a marketing activity. As a result, the Company gain a market share by 69 percent of seaweed snack in this latest September including the revenue from

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

2017 PERFORMANCE ANALYSIS (YoY) In 3Q 2017, the Company once again achieved an outstanding top and bottom line performance compared to the same quarter last year supported by; 1) The consolidation of

30 September 2019, other income totaled THB 7.89 million, a decrease of THB 6.94 million. The mainly reason is the Company had gain on exchange rate in last year that was in line with the Thai Baht

transfer of FKRMM which is deemed as the 322,500,000 THB to 377,500,000THB .00 THB per share. he amendment to Clause 4 in the memorandum of association to be in line with the increase of the Approve the

financial statement showed the profit (attributable to owners of the Company) of THB 1,074.16 million or THB 0.74 per share, decreasing by THB 878.15 million. The main reasons due to the RG’s Power Plant had

and grasp opportunities that each goal presents.Srettha Thavisin, Prime Minister and Minister of Finance, attended the event to share his expectations regarding sustainability in Thailand's business